Organigram Holdings Inc. (NASDAQ:OGI) Q1 2023 Earnings Call Transcript

And we still had some restrictions around COVID, and I think you’re going to continue to see some opportunities of growth in the marketplace. But I think long term, this is — I’m happy to be in this space. It’s really exciting. I think the consumers are going to continue to come. And will the government regulations change to make it easier to compete. I’d love to see the removal of 10-milligram tap on edibles because we have a very strong and thriving Edibles business that would benefit from that. We know we’re not offering consumers ideally what they’re looking for with a cap on 10 milligrams. We look at Colorado market that has edible at 15% of the market. And on average, people are buying 100 milligrams at a time. So, there is opportunity, certainly if regulations change to address that.

I’d love to see CBD be coupled from THC and the opportunity to sell CBD through pharmacies and natural grocery stores. We have a great brand in Monjour that has pure CBD gummies and with other minor cannabinoids that would be a great opportunity. But again, we all know that regulations take a long time to change. So, we are involved with our industry association. We are at the table at ISED talking about what the industry needs to continue to grow. And I am confident that it will change over time. I just don’t believe it will change fast enough for some of the LPs that are struggling today.

Operator: And there are no further questions at this time. Ms. Beena Goldenberg, I’ll turn the call back over to you for some final closing remarks.

Beena Goldenberg: Well, great. Thank you, everybody, for joining us today. We’re excited about the quality of the results we reported, and we look forward to providing further updates throughout the year. So for everyone, have a great day, and we’ll speak soon.

Operator: This concludes today’s conference call. Thank you for your participation. You may now disconnect.